CTOs on the Move

option one

www.oohme.com

 
option one is a Corona, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.oohme.com
  • 830 E Parkridge Ave
    Corona, CA USA 92879
  • Phone: 951.273.0190

Executives

Name Title Contact Details

Similar Companies

OCO BioMedical

OCO BioMedical is a Albuquerque, NM-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Professional Hospital Supply

PHS broke ground in August 2003 on a 212,000-square-foot facility on almost 12 acres in Fairfield, Calif. Occupancy was anticipated for late 2003 or early 2004.

Inspire Medical Systems

Inspire Medical Systems, Inc. has developed the world`s first fully implanted neurostimulation device approved by the FDA for the treatment of Obstructive Sleep Apnea (OSA). The Inspire system uses well-established neurostimulation technologies and incorporates a proprietary algorithm that stimulates key airway muscles based on a patient`s unique breathing patterns. Inspire therapy is designed to reduce OSA severity and improve quality of life for patients living with this challenging condition. Inspire therapy works inside your body, and with your natural breathing process. It might be right for you if you have been diagnosed with OSA, and can`t use or don`t get relief from CPAP/BiPAP.

Osiris Therapeutics

Osiris Therapeutics, Inc. is a leading stem cell company focused on developing and marketing products to treat medical conditions in the inflammatory, autoimmune, orthopedic and cardiovascular areas. Osiris’ stem cell products have significant therapeutic potential because of their ability to regulate inflammation, promote tissue regeneration and prevent pathological scar formation. In Biosurgery, we harness the ability of cells and novel constructs to promote the body`s natural healing. The goals are to improve surgical outcomes and offer better treatment options for patients and physicians. We like a challenge, so the focus is in areas where we believe we can have a significant impact. Difficult indications and challenging cases are targeted. Osiris has been studying tissue engineering since the beginning, and its dedicated team conducted groundbreaking research in the field. The work in bone led to the development of the successful product Osteocel, now owned by NuVasive Inc. Now, application of these technologies is being expanded beyond bone, to soft tissues, such as cartilage and tendon, and also wound healing.

Solx

Solx is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.